Zdrowie i gospodarka · 02/11/2018
FDA Announces Draft Guidance for Chronic Hepatitis B Virus Infection Treatment
The FDA is releasing a draft guidance to help pharmaceutical companies develop effective treatments for chronic hepatitis B virus infection, covering the entire drug development process from initial testing to post-marketing phases.